• Latest Posts

Cellectis has Discovered an ‘On-Switch’ to Make CAR-T Safer and Better Controlled

10 Hot European Biotechs to watch in 2016

CAR-T Phase II: 93% Complete Remission in Children with Relapsed Leukemia!

Cellectis’ CEO: “I’m just trying to be realistic, CAR-T is not THE miracle cure for Cancer”


Why has the Universal CAR-T Treatment For Leukemia Hooked TWO Big Pharmas at Once?

What Happened this Week? BIO-Europe 2015, mRNA deal, Cellectis CAR-T

Cellectis’ Miraculous Saving of a Baby Girl. What’s the impact on the CAR-T field?

Cellectis UCART Milestone: One step closer to a Universal CAR-T Therapy for Blood Cancer

The 9 EU-based Billion-Euro Biotechs you Should (really) Know

Paris is Europe’s biggest Biocluster, but nobody knows it …